Report Overview
Organs On Chip Market is forecasted to rise at a 26.82% CAGR, reaching USD 0.63 billion in 2031 from USD 0.15 billion in 2025.
An organ-on-a-chip (OOC) is a functional microchip housing living cells that have the possibility of simulating the activities, mechanics, and physiological response of entire organs and organ systems, a type of artificial organ. Each organ-on-chip is about the size of a coin and contains microfluidic channels, which are lined by living human cells and interfaced with a human artificial vasculature. The organs-on-chip market has been on a steady growth pace because of the rising need for effective drug discovery and development, increasing demand for alternatives for animal models in research, increasing drug repurposing approaches, and government regulations and grants for the research. The increasing research and funding for the development of the organ-on-chip model, along with the demand for personalized medication and vast application of the chip, such as disease modelling, patient stratification, and phenotypic screening, has also led to market growth.
However, the high cost of the chip and the complexities of mimicking human organs pose a challenge for the growth of the market to continue. Therefore, the key players and researchers are doing agreements and joint ventures and increasing the fund for doing research and developing innovative and new products.
This research study examines the organs-on-chip market based on various segments: type, application, offerings, end-user, and geography. First, a brief overview of the market details key driving factors and challenges. Next, Porter's five forces model comprehensively analyzes the organs-on-chip industry. This is followed by industry value chain analysis which determines the companies which are part of the different processes and contributing to various sectors.
The study also presents in-depth information concerning the development, trends, and industry policies and regulations affecting the organs-on-chip market. Moreover, the research study analyzes the overall regulatory framework of the organs-on-chip sector, offering stakeholders a better understanding of the key factors influencing the overall market environment.
Organs-on-chip Market – Forecasts from 2025 to 2030 is a comprehensive and latest report. It provides vital market information to executives and interested stakeholders to enable them to get vital market information. The report also analyzes the competitive landscape and details strategies of key market players and also plots them on our vendor matrix in four quadrants: leader, follower, challenger, and niche.
Organs On Chip Companies:
AxoSim Inc.
BiomimX SRL
CN Bio
Emulate Inc.
InSphero AG
Organs On Chip Market Scope:
| Report Metric | Details |
|---|---|
| Total Market Size in 2025 | USD 0.15 billion |
| Total Market Size in 2031 | USD 0.63 billion |
| Forecast Unit | Billion |
| Growth Rate | 26.82% |
| Study Period | 2020 to 2031 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2031 |
| Segmentation | Offering, Organ Type, Application, Geography |
| Geographical Segmentation | Americas, Europe Middle East and Africa, Asia Pacific |
| Companies |
|
Market Segmentation
By Offering
By Organ Type
By Application
By End-user
By Geography
Table of Contents
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. ORGANS ON CHIP MARKET BY OFFERING
5.1. Introduction
5.2. Products
5.3. Services
6. ORGANS ON CHIP MARKET BY ORGAN TYPE
6.1. Introduction
6.2. Liver
6.3. Lungs
6.4. Kidney
6.5. Heart
6.6. Others
7. ORGANS ON CHIP MARKET BY APPLICATION
7.1. Introduction
7.2. Drug Discovery
7.3. Regenerative Medicine
7.4. Disease Modeling
7.5. Others
8. ORGANS ON CHIP MARKET BY END-USER
8.1. Introduction
8.2. Pharmaceutical & Biotech Companies
8.3. Research & Academic Institutes
8.4. Others
9. ORGANS ON CHIP MARKET BY GEOGRAPHY
9.1. Introduction
9.2. Americas
9.2.1. USA
9.2.2. Others
9.3. Europe Middle East and Africa
9.3.1. Germany
9.3.2. United Kingdom
9.3.3. Others
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.4.4. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. CN Bio Innovations Ltd
11.2. Emulate Inc.
11.3. BiomimX S.r.l.
11.4. InSphero
11.5. MIMETAS
11.6. TissUse GmbH.
11.7. Hesperos, Inc.
11.8. AlveoliX
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES
Request Customization
Tell us your specific requirements and we will customize this report for you.
Download Free Sample
Get a sample copy of this report with charts, TOC, and methodology.
Speak to Analyst
Ask our analysts any questions you have about this market research report.
Organs On Chip Market Report
Trusted by the world's leading organizations
